Clinical trials recruiting in Nizhny Novgorod, Russia

Phase breakdown

Conditions recruiting in Nizhny Novgorod, Russia

Recruiting trials in Nizhny Novgorod, Russia

• A Long-term Extension Study of PCI-32765 (Ibrutinib)
  NCT01804686 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
  NCT05654454 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis
  NCT07321093 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female)
• A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
  NCT04777357 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female)
• Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
  NCT07052578 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
  NCT07108309 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: Female
• Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
  NCT06472310 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
  NCT06521229 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
  NCT03817502 · Phase: Phase 3 · Ages: 13 Years to 17 Years · Sex: All (male and female)
• Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia
  NCT07251023 · Phase: Phase 3 · Ages: 60 Years to 90 Years · Sex: All (male and female)
• Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination With Oxaliplatin in Elderly Patients as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer.
  NCT06888843 · Phase: Phase 2 · Ages: 70 Years to 90 Years · Sex: All (male and female)
• The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
  NCT03945968 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Nizhny Novgorod, Russia?

12 recruiting trials have at least one study site in Nizhny Novgorod, Russia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.